Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke (DASH)
2026년 5월 15일 업데이트: Bruyère Health Research Institute.
Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke: An Effectiveness-implementation Hybrid Trial.
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
- After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
- Does the effects of the volunteer support last over 3 to 6 months after being discharged home?
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
- Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
- Continue with their usual care plan and receive educational resources from the research team during the study
- Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge
연구 개요
상세 설명
Acute stroke often leads to adult disability in Canada, and about 108,707 Canadians experience a stroke each year.
While most people survive stroke (80 percent) and return home, some survivors are left with ongoing challenges that require them to seek help in the community.
These challenges can lead to stress for the individual and their caregiver.
Research on volunteer-supported home-to-hospital programs has shown positive outcomes.
However, despite the growing evidence that supports volunteer engagement in care transitions, we have yet to determine the impact of a complex psychosocial volunteer-delivered care transition intervention for stroke survivors.
This study will assess whether a volunteer-delivered transitional care intervention, designed by Bruyère Health Research Institute in partnership with March of Dimes Canada (MODC), for adults discharged home from a stroke rehabilitation unit following an acute stroke can improve coping compared to usual care.
MODC will implement the volunteer-support transition program across two Ontario regions for stroke rehabilitation sites.
Those allocated to the intervention group will receive an initial visit from the Volunteer Coordinator and then weekly one-on-one visits by a trained volunteer for eight weeks.
The volunteer may assist the study participant with instrumental daily living activities and psychosocial and informational support.
Those not receiving the intervention will receive educational material at 4- and 8-week time points in addition to their usual care.
All study participants will complete validated patient-reported outcome measures at 3- and 6-months post-hospital discharge.
연구 유형
중재적
등록 (추정된)
840
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
- 이름: Michelle LA Nelson, MA, PhD, FAHA, FWSO
- 전화번호: 647-938-4425
- 이메일: mla.nelson@uottawa.ca
연구 연락처 백업
- 이름: Research Coordinator
- 이메일: TMoni@bruyere.org
연구 장소
-
-
Ontario
-
Ottawa, Ontario, 캐나다
- Bruyère Health Élisabeth-Bruyère Hospital
-
Toronto, Ontario, 캐나다
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, 캐나다
- Hennick Bridgepoint Hospital
-
Toronto, Ontario, 캐나다
- Providence Healthcare (Unity Health Toronto)
-
Toronto, Ontario, 캐나다
- Toronto Rehabilitation Institute (UHN)
-
Toronto, Ontario, 캐나다
- West Park Healthcare Centre (UHN)
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
아니
설명
Inclusion Criteria:
- Confirmed diagnosis of stroke
- Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
- Lived at home pre-stroke
- Discharged directly home (to own residence or that of a family member)
- Live in one of the program implementation areas (i.e., Toronto, Ottawa)
Exclusion Criteria:
- Discharged to additional hospital inpatient care, nursing home, or other long-term care
- Inability to communicate in English
- Inability to provide informed consent due to cognitive deficits
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Group A: DASH group
Participants will receive the DASH intervention + Usual Care + Educational Resources
|
One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services). |
|
간섭 없음: Group B: Usual care group
Participants will receive the Usual Care + Educational Resources
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
기간: Measured at 3 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge.
Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
|
Measured at 3 months post-hospital discharge
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
기간: Measured at 3 months and 6 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure.
Each item is scored from 0 to 10, with total scores ranging from 0 to 100.
Change in total score will be calculated between time points.
Higher scores indicate greater difficulty coping.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
기간: Measured at 3 months and 6 months post-hospital discharge
|
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors.
Each item is scored on a 5-point Likert scale (1 to 5).
Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245).
Higher scores indicate better quality of life.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
기간: Measured at 3 months and 6 months post-hospital discharge
|
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure.
Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
기간: Measured at 3 months and 6 months post-hospital discharge
|
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation.
Each item is scored on a 4-point scale.
Total scores range from 20 to 80, with higher scores indicating greater loneliness.
|
Measured at 3 months and 6 months post-hospital discharge
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (추정된)
2026년 6월 1일
기본 완료 (추정된)
2028년 1월 1일
연구 완료 (추정된)
2028년 4월 1일
연구 등록 날짜
최초 제출
2026년 5월 11일
QC 기준을 충족하는 최초 제출
2026년 5월 11일
처음 게시됨 (실제)
2026년 5월 15일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 5월 18일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 5월 15일
마지막으로 확인됨
2026년 5월 1일
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 191308
- 5161 (기타 식별자: Clinical Trials Ontario)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
미정
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .